[18F]Flutemetamol
DrugNo drug is administered in this intervention. These are scanned images being reviewed, previously acquired in various GE-067 studies.
Other names: Flutemetamol
NCT Number: NCT01672827
To Evaluate the Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]flutemetamol Positron Emission Tomography (PET) Images.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No drug is administered in this intervention. These are scanned images being reviewed, previously acquired in various GE-067 studies.
Other names: Flutemetamol
Time frame: Post flutemetamol administration
Statistical analysis of summary of the blinded visual PET Image Interpretations without Anatomic Images. This data consists of image interpretations by 5 Readers and No subjects were dosed in this study. These Readers examined the PET images for evidence of amyloid plaque.
Time frame: Post flutemetamol administration
Statistical analysis of summary of sensitivity of blinded visual PET image interpretations without anatomic images. This data consists of image interpretations by 5 Readers and No subjects were dosed in this study.These Readers examined the PET images for evidence of amyloid plaque.
Time frame: Post Flutemetamol Injection
Statistical analysis of Inter-Reader Agreement of PET Images without anatomic Images. This data consists of image interpretations by investigators and No subjects were dosed in this study.
GE Healthcare
Industry
A Study to Evaluate the Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04073628
Alzheimer Disease, Alzheimer's Disease
Albany, New York, United States
View Trial DetailsNCT00647478
Alzheimer Disease, Alzheimer's Disease
Paris, France
View Trial DetailsNCT06595030
Alzheimer Disease, Alzheimer's Disease
Menands, New York, United States
View Trial DetailsNCT04426539
Alzheimer Disease, Alzheimer's Disease
Philadelphia, Pennsylvania, United States
View Trial Details